Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Moderna’s chief exec expects to have COVID-19 vaccine data in November

If data is promising, company could seek emergency use authorisation in the US in December

- PMLiVE

UK government invests in human challenge trials for COVID-19

The trials could begin in 2021 if approved by regulators

- PMLiVE

Novartis scores CHMP backing for cholesterol drug Leqvio

Potential first-in-class treatment moves closer to EU approval

Time to tear down the wallpaper?

By James Mayfield

- PMLiVE

Galapagos mid-stage trial failure raises concerns for Gilead deal

Investigational osteoarthritis treatment misses primary endpoint in phase 2 study

- PMLiVE

WHO trial casts doubt on remdesivir’s efficacy

Drug's developer Gilead hits back at the findings

- PMLiVE

Pfizer CEO pushes back COVID-19 vaccine submission to November

Company previously said it would seek approval by October

- PMLiVE

How Far Do You Want To Go?

Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…

OPEN Health

- PMLiVE

Every superhero has an origin story – what’s yours?

By Blair Hesp

“Fishbowl” Web Meeting for Internal POA Discussions: a Customer Story

Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting.

Impetus Digital

- PMLiVE

Embracing the QR code: a health and humanity perspective

Lately, you’ll be noticing them everywhere – the humble QR code is making a comeback. Once widely adopted in 2011, the codes’ usage had pretty much gone out of fashion...

11 London

- PMLiVE

Lilly buys biotech firm Disarm Therapeutics for $135m

Deal could eventually be worth up to $1.36bn

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links